Bet_Noire / iStockphoto.com
The Pharmaceutical Research and Manufacturers of America (PhRMA) has urged the US Trade Representative (USTR) to protect US innovators abroad.
If you have already subscribed please login.
If you have any technical issues please email tech support.
PhRMA, USTR, innovation, patent, Special 301 Report, medicines, IP protection, market access, barriers, biopharmaceutical